Salveen Richter
Stock Analyst
(3.20)
# 1,157
Out of 4,648 analysts
187
Total ratings
41.57%
Success rate
3.05%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Maintains: Neutral | $63 → $70 | $75.75 | -7.59% | 9 | Oct 30, 2024 | |
| NTLA Intellia Therapeutics | Maintains: Neutral | $31 → $20 | $15.14 | +32.10% | 7 | Oct 25, 2024 | |
| MRNA Moderna | Maintains: Buy | $178 → $139 | $53.54 | +159.62% | 8 | Sep 16, 2024 | |
| RLAY Relay Therapeutics | Reinstates: Buy | $20 | $5.85 | +241.88% | 2 | Sep 10, 2024 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $198 → $370 | $269.95 | +37.06% | 5 | Aug 16, 2024 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $66 → $74 | $28.56 | +159.10% | 5 | Aug 9, 2024 | |
| QURE uniQure | Maintains: Neutral | $6 → $10 | $5.56 | +79.86% | 5 | Aug 2, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $67 → $76 | $51.06 | +48.84% | 3 | Aug 2, 2024 | |
| IONS Ionis Pharmaceuticals | Maintains: Sell | $33 → $37 | $38.44 | -3.75% | 3 | Aug 2, 2024 | |
| SAGE Sage Therapeutics | Maintains: Neutral | $19 → $11 | $5.81 | +89.33% | 11 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $44.83 | +18.22% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $50 | $27.21 | +83.76% | 4 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $5 | $5.26 | -4.94% | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $316.91 | +10.44% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $81 | $8.18 | +890.83% | 3 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $472.80 | +18.23% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $5 | $4.51 | +10.86% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $15.89 | -68.53% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $188 → $215 | $123.07 | +74.70% | 3 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $11.33 | -2.91% | 1 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $3.00 | +933.33% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $287.62 | -21.77% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.96 | +455.56% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.27 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $8.29 | +261.88% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $14 | $0.95 | +1,373.68% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $6.64 | +35.54% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $1.34 | +123.88% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $15 → $12 | $14.62 | -17.92% | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $3.76 | +59.57% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $50.63 | -15.07% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $370 | $173.52 | +113.23% | 2 | Oct 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $796 → $970 | $828.84 | +17.03% | 9 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $2 → $3 | $0.46 | +547.95% | 6 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $4 | $1.04 | +284.62% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $52 → $46 | $50.59 | -9.07% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $1.76 | +13.64% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $11.63 | +759.85% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $28 | $15.56 | +79.95% | 2 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $80 | $89.84 | -10.95% | 3 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $30 | $0.60 | +4,862.78% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $104.82 | -52.30% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $20.06 | +124.33% | 1 | Mar 17, 2020 |
Incyte
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $75.75
Upside: -7.59%
Intellia Therapeutics
Oct 25, 2024
Maintains: Neutral
Price Target: $31 → $20
Current: $15.14
Upside: +32.10%
Moderna
Sep 16, 2024
Maintains: Buy
Price Target: $178 → $139
Current: $53.54
Upside: +159.62%
Relay Therapeutics
Sep 10, 2024
Reinstates: Buy
Price Target: $20
Current: $5.85
Upside: +241.88%
Alnylam Pharmaceuticals
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $269.95
Upside: +37.06%
Apellis Pharmaceuticals
Aug 9, 2024
Maintains: Buy
Price Target: $66 → $74
Current: $28.56
Upside: +159.10%
uniQure
Aug 2, 2024
Maintains: Neutral
Price Target: $6 → $10
Current: $5.56
Upside: +79.86%
Ultragenyx Pharmaceutical
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $51.06
Upside: +48.84%
Ionis Pharmaceuticals
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $38.44
Upside: -3.75%
Sage Therapeutics
Jul 26, 2024
Maintains: Neutral
Price Target: $19 → $11
Current: $5.81
Upside: +89.33%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $44.83
Upside: +18.22%
Feb 29, 2024
Maintains: Buy
Price Target: $73 → $50
Current: $27.21
Upside: +83.76%
Feb 16, 2024
Maintains: Neutral
Price Target: $11 → $5
Current: $5.26
Upside: -4.94%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $316.91
Upside: +10.44%
Feb 7, 2024
Reinstates: Buy
Price Target: $81
Current: $8.18
Upside: +890.83%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $472.80
Upside: +18.23%
Sep 13, 2023
Downgrades: Neutral
Price Target: $5
Current: $4.51
Upside: +10.86%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $15.89
Upside: -68.53%
Jun 23, 2023
Maintains: Buy
Price Target: $188 → $215
Current: $123.07
Upside: +74.70%
Mar 2, 2023
Maintains: Neutral
Price Target: $10 → $11
Current: $11.33
Upside: -2.91%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $3.00
Upside: +933.33%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $287.62
Upside: -21.77%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.96
Upside: +455.56%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.27
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $8.29
Upside: +261.88%
Nov 10, 2022
Maintains: Buy
Price Target: $25 → $14
Current: $0.95
Upside: +1,373.68%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $6.64
Upside: +35.54%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $1.34
Upside: +123.88%
Nov 4, 2022
Downgrades: Sell
Price Target: $15 → $12
Current: $14.62
Upside: -17.92%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $3.76
Upside: +59.57%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $50.63
Upside: -15.07%
Oct 26, 2022
Upgrades: Buy
Price Target: $370
Current: $173.52
Upside: +113.23%
Oct 3, 2022
Maintains: Buy
Price Target: $796 → $970
Current: $828.84
Upside: +17.03%
Aug 19, 2022
Maintains: Sell
Price Target: $2 → $3
Current: $0.46
Upside: +547.95%
May 24, 2022
Maintains: Neutral
Price Target: $7 → $4
Current: $1.04
Upside: +284.62%
May 24, 2022
Maintains: Neutral
Price Target: $52 → $46
Current: $50.59
Upside: -9.07%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $1.76
Upside: +13.64%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $11.63
Upside: +759.85%
May 12, 2022
Maintains: Neutral
Price Target: $48 → $28
Current: $15.56
Upside: +79.95%
Dec 6, 2021
Initiates: Neutral
Price Target: $80
Current: $89.84
Upside: -10.95%
Mar 4, 2021
Upgrades: Buy
Price Target: $28 → $30
Current: $0.60
Upside: +4,862.78%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $104.82
Upside: -52.30%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $20.06
Upside: +124.33%